Houston, TX
October 29, 2025
"The future of oncology will not be determined only by novel therapies, but also by how effectively healthcare systems deliver them safely and affordably. Comprehensive PGx testing in oncology care, anchored in proper use of anticancer medications but extending across multiple drug classes, provides a proven mechanism to reduce severe toxicity, preserve treatment efficacy, and control costs." - Houda Hachad, PharmD, M.Res
Houda's article, Pharmacogenomics In Oncology: Unlocking Value, Safety, And ROI For Healthcare Systems, covers the scope and impact of PGx in oncology across multiple factors and variants. Read the full article in Healthcare Business Today: https://www.healthcarebusinesstoday.com/pharmacogenomics-oncology-roi/